SCHEMBL24508596

SCHEMBL24508596

CC(C)Nc1cc(Br)ncc1C(=O)N[C@H]1CC[C@H](CO)CC1

nearest known ligand 0.48

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 20/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29709747 1.00 IRAK4 (0.48) IRAK4
SCHEMBL29709894 1.00 IRAK4 (0.48) IRAK4
SCHEMBL20476036 0.84 IRAK4 (0.54) IRAK4
SCHEMBL29709731 0.80 IRAK4 (0.43) IRAK4
SCHEMBL30545154 0.80 IRAK4 (0.44) IRAK4
SCHEMBL31436622 0.77 IRAK4 (0.61) IRAK4
SCHEMBL26598605 0.77 IRAK4 (0.61) IRAK4
SCHEMBL24608428 0.74 IRAK4 (0.72) IRAK4
SCHEMBL29751427 0.74 IRAK4 (0.72) IRAK4
SCHEMBL21379161 0.74 IRAK4 (0.57) IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022147465-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-07-07 — — WO disclosed
WO-2022125790-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-06-16 — — WO disclosed
Send feedback